Vincent has over 10 years of experience leading biostatistics and epidemiology in the medical field, including as Professor and Director of the Biostatistics and Epidemiology Core at a major US children’s hospital. He joined IDDI in 2023, where he advises biotech and pharmaceutical companies on clinical trial study design, with a focus on creating protocols that are both scientifically rigorous and operationally realistic.

Vincent has authored over 120 peer-reviewed publications and is recognized for translating complex statistical methods into clear, defensible findings. This strength has become a key asset in regulatory and stakeholder communication across the clinical development process.

He applies advanced statistical methods such as adaptive design clinical trials, Bayesian designs, survival analysis, longitudinal modeling, and sample size determination to help clinical teams build statistically credible, regulator-aligned strategies. He also supports the transformation of early trial concepts into statistically grounded study designs, reducing ambiguity, preventing protocol amendments, and improving clarity for internal and external decision-makers.

Research Gate Profile

Back to Team